NCT03788369
Terminated
N/A
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization, a Non-randomized, Prospective, Open-label Registry in Real-world Practice
Seung-Jung Park1 site in 1 country6 target enrollmentApril 5, 2019
ConditionsPercutaneous Coronary RevascularizationCoronary StenosisCoronary Artery Disease ProgressionCoronary Artery Bypass Grafting
InterventionsHybrid Coronary Revascularization
Overview
- Phase
- N/A
- Intervention
- Hybrid Coronary Revascularization
- Conditions
- Percutaneous Coronary Revascularization
- Sponsor
- Seung-Jung Park
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
- Status
- Terminated
- Last Updated
- 17 days ago
Overview
Brief Summary
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Investigators
Seung-Jung Park
Professor, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Asan Medical Center
Eligibility Criteria
Inclusion Criteria
- •Age 20 and more
- •Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
- •Written consent
Exclusion Criteria
- •Previous CABG(coronary artery bypass graft)
- •Life expectancy ≤1 year
Arms & Interventions
Multivessel coronary artery disease
must include left anterior descending artery
Intervention: Hybrid Coronary Revascularization
Outcomes
Primary Outcomes
a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
Time Frame: 5 years
Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.
Secondary Outcomes
- Stent thrombosis(5 years)
- Procedural success(5 days)
- a composite event of cardiac death or myocardial infarction(5 years)
- TVR(Target Vessel Revascularization)(5 years)
- TLR(Target Lesion Revascularization)(5 years)
- All death(5 years)
- Cardiac death(5 years)
- Myocardial infarction(5 years)
- a composite event of all death or myocardial infarction(5 years)
- Cerebrovascular event(5 years)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
N/A
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel DiseaseMultivessel Coronary Artery DiseaseNCT02226900InCor Heart Institute60
Completed
N/A
HCR vs. CABG StudyCoronary Artery DiseaseNCT02892474Emory University75
Not Yet Recruiting
N/A
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery DiseaseCoronary Artery DiseaseDiffuse Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)NCT06710210University Hospital, Geneva150
Terminated
N/A
FUNctional eFficacy of Hybrid coronAry REvascularizationCoronary Artery DiseaseNCT04698460Tomsk National Research Medical Center of the Russian Academy of Sciences13
Completed
Phase 2
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery DiseaseHeart DiseaseMyocardial IschaemiaCoronary DiseaseCoronary Artery DiseaseNCT01035567Silesian Centre for Heart Diseases200